In today’s recent session, 7.55 million shares of the Avenue Therapeutics Inc (NASDAQ:ATXI) have been traded, and its beta is -0.24. Most recently the company’s
In last trading session, Avenue Therapeutics Inc (NASDAQ:ATXI) saw 1.22 million shares changing hands with its beta currently measuring -0.27. Company’s recent per share price
Avenue Therapeutics Inc (NASDAQ:ATXI) has a beta value of -0.27 and has seen 1.13 million shares traded in the last trading session. The company, currently
In the last trading session, 2.75 million Avenue Therapeutics Inc (NASDAQ:ATXI) shares changed hands as the company’s beta touched -0.24. With the company’s per share
In the latest trading session, 0.47 million Avenue Therapeutics Inc (NASDAQ:ATXI) shares changed hands as the company’s beta touched -0.24. With the company’s most recent
In recent trading session, Avenue Therapeutics Inc (NASDAQ:ATXI) saw 0.77 million shares changing hands at last check today with its beta currently measuring -0.24. Company’s
Avenue Therapeutics Inc (NASDAQ:ATXI) has a beta value of -0.25 and has seen 2.46 million shares traded in the last trading session. The company, currently
During the last session, Avenue Therapeutics Inc (NASDAQ:ATXI)’s traded shares were 1.79 million, with the beta value of the company hitting -0.24. The 52-week high
In the last trading session, 5.86 million shares of the Avenue Therapeutics Inc (NASDAQ:ATXI) were traded, and its beta was -0.25. Most recently the company’s
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
